NEW YORK, March 17 (Reuters) – Nvidia (NVDA.O), has won Beijing’s approval to sell its second-most powerful artificial intelligence chips to China and is also preparing a version of the Groq AI chip that can be sold to the Chinese market, sources familiar with the matter said. Read...
Read MoreREDWOOD CITY, Calif., March 17, 2026 /PRNewswire/ — Appdome, the leader in protecting the mobile economy, today unveiled DefenseOS™, its governed execution environment for high-performance security, anti-fraud, and API protection controls in mobile applications. Read...
Read MoreAI arrived in the enterprise before the enterprise was ready for it. That’s not a criticism of AI. ChatGPT, Gemini, and Copilot are remarkable tools. Enterprises are paying for them, sanctioning them, and encouraging their use. But pair that with AI sprawl driven by personal preferences and a variety of models, and control slips fast. Organizations aren’t falling behind on AI adoption. They’re falling behind on scaling it. Read...
Read MoreFor nearly a century, scientists have chased the “holy grail” of clean power: nuclear fusion. Today, that pursuit has shifted from the lab to the commercial market. In this episode of Business Innovators Unplugged, Commonwealth Fusion Systems (CFS) Chief Marketing Officer Joe Paluska sat down to break down the timeline, the tech and the geopolitical stakes of bringing a “star in a jar” to the grid. Read more...
Read MoreBOSTON–(BUSINESS WIRE)–Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting-edge drug discovery technologies, today announced an agreement with AbbVie to develop a new antibody platform to discover potent, specific, and effective antibodies against targets that are difficult to address with current technologies. As part of the multi-year agreement, Alloy will receive an upfront payment, as well as an additional payment in connection with the delivery of the platform to AbbVie. Read more...
Read More
